Drug Makers Nervously Eye High Court On Generics
In the shadow of the Supreme Court, the debate over authorized generics is heating up as brand-name drug companies and generic makers prepare to do battle over what they both consider...To view the full article, register now.
Already a subscriber? Click here to view full article